{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:02:33Z","timestamp":1790809353298,"version":"4.1.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,3,30]],"date-time":"2016-03-30T00:00:00Z","timestamp":1459296000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1038\/ejhg.2016.28","type":"journal-article","created":{"date-parts":[[2016,3,30]],"date-time":"2016-03-30T18:26:54Z","timestamp":1459362414000},"page":"1578-1583","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["ASAH1 variant causing a mild SMA phenotype with no myoclonic epilepsy: a clinical, biochemical and molecular study"],"prefix":"10.1038","volume":"24","author":[{"given":"Massimiliano","family":"Filosto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Aureli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Castellotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domitilla","family":"Schiumarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Valsecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Lualdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Mazzotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Pensato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Rota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Gellera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirella","family":"Filocamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Padovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,30]]},"reference":[{"key":"BFejhg201628_CR1","doi-asserted-by":"publisher","first-page":"11098","DOI":"10.1074\/jbc.270.19.11098","volume":"270","author":"K Bernardo","year":"1995","unstructured":"Bernardo K, Hurwitz R, Zenk T et al: Purification, characterization, and biosynthesis of human acid ceramidase. J Biol Chem 1995; 270: 11098\u201311102.","journal-title":"J Biol Chem"},{"key":"BFejhg201628_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/geno.1999.5940","volume":"62","author":"CM Li","year":"2000","unstructured":"Li CM, Park JH, He X et al: The human acid ceramidase gene (ASAH): structure, chromosomal location, mutation analysis, and expression. Genomics 2000; 62: 223\u2013231.","journal-title":"Genomics"},{"key":"BFejhg201628_CR3","first-page":"1645","volume-title":"The Metabolic Basis of Inherited Disease","author":"HW Moser","year":"1989","unstructured":"Moser HW, Moser AB, Chen WW, Schram AW . Ceramidase deficiency: Farber lipogranulomatosis In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic Basis of Inherited Disease Vol. II 6th ed. McGraw-Hill: New York, USA, 1989, pp 1645\u20131654."},{"key":"BFejhg201628_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00439-013-1358-4","volume":"133","author":"PD Stenson","year":"2014","unstructured":"Stenson PD, Mort M, Ball EV, Shaw K, Phillips A, Cooper DN : The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet 2014; 133: 1\u20139.","journal-title":"Hum Genet"},{"key":"BFejhg201628_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.ajhg.2012.05.001","volume":"91","author":"J Zhou","year":"2012","unstructured":"Zhou J, Tawk M, Tiziano FD et al: Spinal muscular atrophy associated with progressive myoclonic epilepsy is caused by mutations in ASAH1. Am J Hum Genet 2012; 91: 5\u201314.","journal-title":"Am J Hum Genet"},{"key":"BFejhg201628_CR6","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/cge.12307","volume":"86","author":"DA Dyment","year":"2014","unstructured":"Dyment DA, Sell E, Vanstone MR et al: Evidence for clinical, genetic and biochemical variability in spinal muscular atrophy with progressive myoclonic epilepsy. Clin Genet 2014; 86: 558\u2013563.","journal-title":"Clin Genet"},{"key":"BFejhg201628_CR7","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1055\/s-2002-37087","volume":"33","author":"G Haliloglu","year":"2002","unstructured":"Haliloglu G, Chattopadhyay A, Skorodis L et al: Spinal muscular atrophy with progressive myoclonic epilepsy: report of new cases and review of the literature. Neuropediatrics 2002; 33: 314\u2013319.","journal-title":"Neuropediatrics"},{"key":"BFejhg201628_CR8","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.5334\/ojb.ab","volume":"1","author":"M Filocamo","year":"2014","unstructured":"Filocamo M, Mazzotti R, Corsolini F et al: Cell line and DNA biobank from patients affected by genetic diseases. Open J Bioresources 2014; 1: e2.","journal-title":"Open J Bioresources"},{"key":"BFejhg201628_CR9","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1093\/hmg\/ddl171","volume":"15","author":"PJ Smith","year":"2006","unstructured":"Smith PJ, Zhang C, Wang J, Chew SL, Zhang MQ, Krainer AR : An increased specificity score matrix for the prediction of SF2\/ASF-specific exonic splicing enhancers. Hum Mol Genet 2006; 15: 2490\u20132508.","journal-title":"Hum Mol Genet"},{"key":"BFejhg201628_CR10","doi-asserted-by":"publisher","first-page":"219227","DOI":"10.1016\/j.gene.2005.07.015","volume":"366","author":"M Wang","year":"2006","unstructured":"Wang M, Marin A : Characterization and prediction of alternative splice sites. Gene 2006; 366: 219227.","journal-title":"Gene"},{"key":"BFejhg201628_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/j.1399-0004.1989.tb03364.x","volume":"36","author":"Y Ben-Yoseph","year":"1989","unstructured":"Ben-Yoseph Y, Gagn\u00e9 R, Parvathy MR, Mitchell DA, Momoi T : Leukocyte and plasma N-laurylsphingosine deacylase (ceramidase) in Farber disease. Clin Genet 1989; 36: 38\u201342.","journal-title":"Clin Genet"},{"key":"BFejhg201628_CR12","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/j.1471-4159.2008.05591.x","volume":"107","author":"F Scandroglio","year":"2008","unstructured":"Scandroglio F, Venkata JK, Loberto N : Lipid content of brain, brain membrane lipid domains, and neurons from acid sphingomyelinase deficient mice. J Neurochem 2008; 107: 329\u2013338.","journal-title":"J Neurochem"},{"key":"BFejhg201628_CR13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/0014-5793(92)80193-K","volume":"300","author":"L Riboni","year":"1992","unstructured":"Riboni L, Bassi R, Sonnino S, Tettamanti G : Formation of free sphingosine and ceramide from exogenous ganglioside GM1 by cerebellar granule cells in culture. FEBS Lett 1992; 300: 188\u2013192.","journal-title":"FEBS Lett"},{"key":"BFejhg201628_CR14","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1194\/jlr.M600344-JLR200","volume":"48","author":"M Valsecchi","year":"2007","unstructured":"Valsecchi M, Mauri L, Casellato R et al: Ceramide and sphingomyelin species of fibroblasts and neurons in culture. J Lipid Res 2007; 48: 417\u2013424.","journal-title":"J Lipid Res"},{"key":"BFejhg201628_CR15","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/epi.12977","volume":"56","author":"G Rubboli","year":"2015","unstructured":"Rubboli G, Veggiotti P, Pini A et al: Spinal muscular atrophy associated with progressive myoclonic epilepsy: A rare condition caused by mutations in ASAH1. Epilepsia 2015; 56: 692\u2013698.","journal-title":"Epilepsia"},{"key":"BFejhg201628_CR16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.nmd.2014.11.007","volume":"25","author":"BG Gir\u00e1ldez","year":"2015","unstructured":"Gir\u00e1ldez BG, Guerrero-L\u00f3pez R, Ortega-Moreno L et al: Uniparental disomy as a cause of spinal muscular atrophy and progressive myoclonic epilepsy: phenotypic homogeneity due to the homozygous c.125C>T mutation in ASAH1. Neuromuscul Disord 2015; 25: 222\u2013224.","journal-title":"Neuromuscul Disord"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ejhg201628.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg201628","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ejhg201628.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:17:23Z","timestamp":1684430243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ejhg201628"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,30]]},"references-count":16,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["BFejhg201628"],"URL":"https:\/\/doi.org\/10.1038\/ejhg.2016.28","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,30]]},"assertion":[{"value":"30 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2016","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}